Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis

@article{Zeng2017EffectivenessOM,
  title={Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis},
  author={Liuting Zeng and Kailin Yang},
  journal={Endocrine},
  year={2017},
  volume={59},
  pages={30-38}
}
PurposeTo assess the effectiveness and safety of myoinositol for patients with PCOS.MethodsIn this meta-analysis, data from randomized controlled trials are obtained to assess the effects of myoinositol vs. placebo or western medicine in women with PCOS. The study’s registration number is CRD42017064563. The primary outcomes included total testosterone, estradiol (E2) and the homeostatic model assessment (HOMA) of insulin resistance.ResultTen trials involving 573 patients were included. The… Expand
Impact of myoinositol with metformin and myoinositol alone in infertile PCOS women undergoing ovulation induction cycles - randomized controlled trial
  • P. Prabhakar, R. Mahey, +6 authors N. Bhatla
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2020
TLDR
Myoinositol (4 g) might be used alone as an insulin sensitizer to improve metabolic, hormonal and reproductive outcome in infertile PCOS women. Expand
Does the combination of myo-inositol improve pregnancy outcomes in obese polycystic ovary syndrome women undergoing ovarian stimulation with clomiphene citrate?
TLDR
Compared to ovarian stimulation with CC alone, the combination provides a beneficial effect on endometrial thickness and the number of mature follicles, however, ovulation rates are similar with the two regimens. Expand
Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond
TLDR
The evidence suggests that MI, alone or with DCI in the 40:1 ratio, offers a promising treatment for PCOS and NIDDM. Expand
Improvement of Insulin Sensitivity Increases Pregnancy Rate in Infertile PCOS Women: A Systemic Review
TLDR
Nonsurgical therapeutic strategies that promote superior IS improvement may aid infertile PCOS women to increase their possibility of successful pregnancy regardless of the various interventions. Expand
Inositols in Polycystic Ovary Syndrome: An Overview on the Advances
TLDR
The physiological activities of MI and DCI dictate the dosages and timing of inositol supplementation in the treatment of PCOS and new data on the use of alpha-lactalbumin to boost inositl absorption is discussed. Expand
Current treatment for Polycystic Ovary Syndrome: focus on adolescence.
TLDR
Emerging data support inositol and alpha-lipoic acid as alternative compounds, alone or in combination with the aforementioned strategies, with favourable effects on ovulation, insulin resistance and inflammation, and additional studies are required in adolescents, in order to assess the effectiveness of diet supplements in preventing negative impacts of PCOS on fertility in adult age. Expand
Medical treatment and comorbidity in polycystic ovary syndrome: An updated review
TLDR
The present article gives an update regarding established and upcoming medical treatment for PCOS and for comorbidities of PCOS. Expand
Clinical and Metabolic Effects of Alpha-Lipoic Acid Associated with Two Different Doses of Myo-Inositol in Women with Polycystic Ovary Syndrome
TLDR
In conclusion, ALA + MI positively affects the menstrual regularity of women with PCOS, regardless of their metabolic phenotype, with a more evident effect with a higher dose of MI, which seems to be insulin independent. Expand
Inositols in PCOS
TLDR
The available clinical data suggest that MI, DCI, and their combination in physiological ratio 40:1 with or without other compound could be beneficial for improving metabolic, hormonal, and reproductive aspects of PCOS. Expand
Inositol Treatment for PCOS Should Be Science-Based and Not Arbitrary
TLDR
It is quite surprising to find that inositol-based treatments for PCOS seem to be randomly chosen and are often combined with useless or even counterproductive molecules, all of which can weaken myo-inositol's efficacy. Expand
...
1
2
...

References

SHOWING 1-10 OF 48 REFERENCES
Effects of myo-inositol in women with PCOS: a systematic review of randomized controlled trials
TLDR
An overview on the clinical outcomes of the MYO use as a treatment to improve ovarian function and metabolic and hormonal parameters in women with PCOS is provided. Expand
Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials
TLDR
This systematic review is the analysis of recent randomized clinical trials of inositol(s) in PCOS, in particular myo- and D-chiro-inositol, in order to better elucidate their physiological involvement inPCOS and potential therapeutic use, alone and in conjunction with assisted reproductive technologies, in the clinical treatment of women with PCOS. Expand
A COMPARATIVE STUDY OF MYO INOSITOL VERSUS METFORMIN ON BIOCHEMICAL PROFILE IN POLYCYSTIC OVARIAN SYNDROME IN WOMEN
Objective: PCOS is a common endocrine disorder in women of reproductive age associated with insulin resistance. Metformin and Myo-inositol being insulin sensitizers improve biochemical parameters.Expand
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
  • P. Artini, O. M. Di Berardino, +4 authors V. Cela
  • Medicine
  • Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
  • 2013
TLDR
Myo-inositol administration improves reproductive axis functioning in PCOS patients reducing the hyperinsulinemic state that affects LH secretion, and insulin sensitivity, expressed as glucose-to-insulin ratio and HOMA index resulted significantly improved after 12 weeks of treatment. Expand
Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial.
TLDR
Treatment of PCOS patients with Myo-inositol provided a decreasing of circulating insulin and serum total testosterone as well as an improvement in metabolic factors. Expand
Myo-Inositol in the Treatment of Teenagers Affected by PCOS
TLDR
Administration of MI is a safe and effective method to prevent and correct metabolic disorders in teenagers affected by PCOS and with combination of MI and OCPs antiandrogenic effects are enhanced, negative impact of O CPs on weight gain is balanced, and metabolic profile is improved. Expand
Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS)
TLDR
The two insulin-sensitizers, metformin and myo-inositol, show to be useful in PCOS women in lowering BMI and ameliorating insulin sensitivity, and improving menstrual cycle without significant differences between the two treatments. Expand
Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis
TLDR
High homocysteine levels in women with PCOS are not related to degree of obesity, IR, or androgen levels, and metformin treatment cannot decrease the homocystine levels. Expand
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report.
TLDR
It is the view of the AE-PCOS Society Task Force that PCOS should be defined by the presence of hyperandrogenism, ovarian dysfunction, and/or polycystic ovaries, and the exclusion of related disorders. Expand
Effects of inositol on ovarian function and metabolic factors in women with PCOS: a randomized double blind placebo-controlled trial.
TLDR
A beneficial effect of inositol in improving ovarian function in women with oligomenorrhea and polycystic ovaries is found and the inverse relationship between body mass of the patients and the efficacy of the treatment is found. Expand
...
1
2
3
4
5
...